BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA
172 results:

  • 1. Use of secondary prevention medications in metropolitan and non-metropolitan areas: an analysis of 41 925 myocardial infarctions in Australia.
    Livori AC; Ademi Z; Ilomäki J; Pol D; Morton JI; Bell JS
    Eur J Prev Cardiol; 2024 Mar; 31(5):580-588. PubMed ID: 37987181
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. No effect of remoteness on clinical outcomes following myocardial infarction: An analysis of 43,729 myocardial infarctions in Victoria, Australia.
    Livori AC; Ademi Z; Ilomäki J; Pol D; Morton JI; Bell JS
    Int J Cardiol; 2024 Mar; 398():131593. PubMed ID: 37979791
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Analysis of CD74 Occurrence in Oncogenic Fusion Proteins.
    Vargas J; Pantouris G
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958963
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of cancer.
    Majumder A
    Cells; 2023 Oct; 12(21):. PubMed ID: 37947595
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Functional delineation of the luminal epithelial microenvironment in breast using cell-based screening in combinatorial microenvironments.
    Jokela TA; Dane MA; Smith RL; Devlin KL; Shalabi S; Lopez JC; Miyano M; Stampfer MR; Korkola JE; Gray JW; Heiser LM; LaBarge MA
    Cell Signal; 2024 Jan; 113():110958. PubMed ID: 37935340
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Single-Nucleus Transcriptome Profiling of Locally Advanced Cervical Squamous Cell cancer Identifies Neural-Like Progenitor Program Associated with the Efficacy of Radiotherapy.
    Zhang L; Ma J; Zhou D; Zhou J; Hu B; Ma X; Tang J; Bai Y; Chen H; Jing Y
    Adv Sci (Weinh); 2023 Sep; 10(25):e2300348. PubMed ID: 37424047
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Exploring the Binding Mechanism of nrg1-ERBB3 Complex and Discovery of Potent Natural Products to Reduce Diabetes-Assisted breast cancer Progression.
    Marafie SK; Alshawaf E; Abu-Farha M; Thanaraj TA; Wei DQ; Al-Mulla F; Khan A; Abubaker J; Mohammad A
    Interdiscip Sci; 2023 Sep; 15(3):452-464. PubMed ID: 37389721
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Safety and efficacy of trastuzumab biosimilar plus irinotecan or gemcitabine in patients with previously treated HER2 (ERBB2)-positive non-breast/non-gastric solid tumors: a phase II basket trial with circulating tumor DNA analysis.
    Hyung J; Lee JY; Kim JE; Yoon S; Yoo C; Hong YS; Jeong JH; Kim TW; Jeon S; Jun HR; Jung CK; Jang JP; Kim J; Chun SM; Ahn JH
    ESMO Open; 2023 Jun; 8(3):101583. PubMed ID: 37327700
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinicopathological Characteristics of nrg1 Fusion-Positive Solid Tumors in Korean Patients.
    Cha YJ; Lee C; Joo B; Kim KA; Lee CK; Shim HS
    Cancer Res Treat; 2023 Oct; 55(4):1087-1095. PubMed ID: 37321274
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. RNA Sequencing Identifies Novel nrg1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers.
    Severson E; Achyut BR; Nesline M; Pabla S; Previs RA; Kannan G; Chenn A; Zhang S; Klein R; Conroy J; Sausen M; Sathyan P; Saini KS; Ghosh A; Jensen TJ; Reddy P; Ramkissoon SH
    J Mol Diagn; 2023 Jul; 25(7):454-466. PubMed ID: 37164276
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility.
    Lee NY; Hum M; Amali AA; Lim WK; Wong M; Myint MK; Tay RJ; Ong PY; Samol J; Lim CW; Ang P; Tan MH; Lee SC; Lee ASG
    Hum Genomics; 2022 Nov; 16(1):61. PubMed ID: 36424660
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Drivers of racial, regional, and socioeconomic disparities in late-stage breast cancer mortality.
    Moubadder L; Collin LJ; Nash R; Switchenko JM; Miller-Kleinhenz JM; Gogineni K; Ward KC; McCullough LE
    Cancer; 2022 Sep; 128(18):3370-3382. PubMed ID: 35867419
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Long-Term Follow-Up on Morbidity Among Women With a History of Gestational Diabetes Mellitus: A Systematic Review.
    Flachs Madsen LR; Gerdøe-Kristensen S; Lauenborg J; Damm P; Kesmodel US; Lynge E
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2411-2423. PubMed ID: 35763540
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effects of Oncogene Neuregulin 1 on breast cancer Cells.
    Li Q; Zhu B; Chen J; Wang H; Wu Y; Chen H; He X
    Pak J Biol Sci; 2022 Jan; 25(4):345-352. PubMed ID: 35638529
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. RENORT: a project to analyze patterns of care in radiation oncology in Spain.
    López-Torrecilla J; Palacios Eito A; Gómez-Caamaño A; Salinas Ramos J; Samper Ots P; Rodríguez Pérez A
    Clin Transl Oncol; 2022 Jul; 24(7):1322-1332. PubMed ID: 35028930
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. nrg1 and NRG2 fusion positive solid tumor malignancies: a paradigm of ligand-fusion oncogenesis.
    Nagasaka M; Ou SI
    Trends Cancer; 2022 Mar; 8(3):242-258. PubMed ID: 34996744
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ErbB4-mediated regulation of vasculogenic mimicry capability in breast cancer cells.
    Kawahara R; Simizu S
    Cancer Sci; 2022 Mar; 113(3):950-959. PubMed ID: 34971015
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Microstructural breast tissue characterization: A head-to-head comparison of Diffusion Weighted Imaging and Acoustic Radiation Force Impulse elastography with clinical implications.
    Kapetas P; Clauser P; Milos RI; Vigano S; Bernathova M; Helbich TH; Baltzer PAT
    Eur J Radiol; 2021 Oct; 143():109926. PubMed ID: 34438330
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Ductal adenocarcinoma of the pancreas: subtypes and molecular pathology].
    Schlitter AM; Konukiewitz B; Kasajima A; Reichert M; Klöppel G
    Pathologe; 2021 Sep; 42(5):464-471. PubMed ID: 34402977
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Preclinical and Clinical Characterization of Fibroblast-derived Neuregulin-1 on Trastuzumab and Pertuzumab Activity in HER2-positive breast cancer.
    Guardia C; Bianchini G; Arpí-LLucià O; Menendez S; Casadevall D; Galbardi B; Dugo M; Servitja S; Montero JC; Soria-Jiménez L; Sabbaghi M; Peña R; Madoz-Gúrpide J; Lloveras B; Lluch A; Eroles P; Arribas J; Pandiella A; Gianni L; Rojo F; Rovira A; Albanell J
    Clin Cancer Res; 2021 Sep; 27(18):5096-5108. PubMed ID: 34385295
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.